Cancer drug-tolerant persister cells: from biological questions to clinical opportunities by Bardelli, Russo et. al
https://bit.ly/3CkSE...
#persistercells #DTPs #cancerresistance
@natureportfolio.bsky.social #NRCtop10of2024
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities by Bardelli, Russo et. al
https://bit.ly/3CkSE...
#persistercells #DTPs #cancerresistance
@natureportfolio.bsky.social #NRCtop10of2024
@tamedoncol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ADCs #cancerresistance #targetedtherapy #oncology #openaccess
@tamedoncol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#ADCs #cancerresistance #targetedtherapy #oncology #openaccess
cosmosmagazine.com/nature/bats-...
cosmosmagazine.com/nature/bats-...
@tamedoncol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#testicularcancer #cancerresistance #oncology #openaccess
@tamedoncol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#testicularcancer #cancerresistance #oncology #openaccess
Read more:
obipharma.com/news/bioconj...
#BispecificAntibodies #DualPayloadADC
#ADC #CancerResistance #NextGenADC
Read more:
obipharma.com/news/bioconj...
#BispecificAntibodies #DualPayloadADC
#ADC #CancerResistance #NextGenADC
Strength through diversity: how cancers thrive when clones cooperate
🔓 buff.ly/kQAi97p
#TumourHeterogeneity #TherapyResistance #CancerResistance
Strength through diversity: how cancers thrive when clones cooperate
🔓 buff.ly/kQAi97p
#TumourHeterogeneity #TherapyResistance #CancerResistance
Strength through diversity: how cancers thrive when clones cooperate
🔓 buff.ly/kQAi97p
#TumourHeterogeneity #TherapyResistance #CancerResistance
Strength through diversity: how cancers thrive when clones cooperate
🔓 buff.ly/kQAi97p
#TumourHeterogeneity #TherapyResistance #CancerResistance
www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Meet: Brett Stewart Carver Research Focus: Surgery; Attending
synapse.mskcc.org/synapse/work...
Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
#ProstateCancer #CancerResistance
#AKTpathway
Meet: Brett Stewart Carver Research Focus: Surgery; Attending
synapse.mskcc.org/synapse/work...
Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
#ProstateCancer #CancerResistance
#AKTpathway
The bowhead #whale lives over 200 years, defying Peto’s Paradox.Enhanced #DNARepair, driven by #CIRBP, helps prevent cancer by fixing #mutations.Explains its long, cancer-free life. www.nature.com/articles/s41...
The bowhead #whale lives over 200 years, defying Peto’s Paradox.Enhanced #DNARepair, driven by #CIRBP, helps prevent cancer by fixing #mutations.Explains its long, cancer-free life. www.nature.com/articles/s41...